Back to Selection     Print       Date : 30 Jun 2025
Fund Summary
UTI Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Jun-1999
Corpus(Cr.) 1099.0 Latest NAV 299.0786 As on 29-07-2025
Equity(%) 98.89 52 Week High 299.079
Debt(%) 1.11 52 Week Low 247.991
Others(%) 0.0 Exit Load -
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.26
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kamal Gada
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 28.98%
Top 10 Holdings 46.82%
Top 25 Holdings 82.07%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 72.86
Healthcare 25.0
Cash 1.1
Communication 1.03
Others 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.76
PE Ratio 35.19
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 10.08
Cipla Limited 5.48
Ajanta Pharma Limited 4.92
Procter & Gamble Health Limited 4.30
Dr Reddys Laboratories Limited 4.20
Glenmark Pharmaceuticals Limited 3.99
Lupin Limited 3.53
Apollo Hospitals Enterprise Limited 3.49
DIVI LABORATORIES LTD. 3.47
Fortis Health Care Ltd 3.36
EQ- JUPITER LIFE LINE HOSPITALS LTD 3.07
Gland Pharma Limited 3.00
Cohance Lifesciences Limited 2.81
Max Healthcare Institute Limited 2.79
Eris Lifesciences Limited 2.75
Caplin Point Laboratories Limited 2.73
Krishna Inst of Medical Sciences Ltd. 2.64
Aurobindo Pharma Limited 2.58
Alkem Laboratories Limited 2.12
Aster DM Healthcare Limited 2.09
IPCA Laboratories Limited 1.94
Marksans Pharma Limited 1.80
Sai Life Sciences Limited 1.78
EQ- GLOBAL HEALTH LTD. 1.60
METROPOLIS HEALTHCARE LIMITED 1.55

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
5.64% 10.71% 12.26% 15.85%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-3.02% 2.65% 8.02% 1.23%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
29.43% 26.57% 21.81% 12.27%
 
 
13.76% 14.40% 18.66% 12.84%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
UTI Healthcare Fund (G) 15.52% -0.6627 14.7120% 47.1545 -0.0331
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
UTI Healthcare Fund (G) -12.4772% 0.7528 -0.1697 15.3925 -1.1300
 
Back to Selection